MedCity Pivot Podcast: A Conversation With AliveCor’s Priya Abani
In this episode of the MedCity Pivot Podcast, CEO Priya Abani talks about the evolution of AliveCor, one of the earliest digital health companies.
In this episode of the MedCity Pivot Podcast, CEO Priya Abani talks about the evolution of AliveCor, one of the earliest digital health companies.
The INVEST Digital Health conference, which will spotlight the consumer influence in healthcare, will include a discussion on wearables. It is scheduled for October 29 at Pegasus Park in Dallas. Register today!
AliveCor CEO Priya Abani argues that Apple has made a habit of taking intellectual property from smaller medical device firms in order to improve the functionalities its Apple Watch. She also believes that Apple has been able to avoid taking accountability for this by “bombarding” smaller companies with litigation it knows they won’t be able to afford — a claim that medical IP lawyers have backed up.
A look at how tapping real world evidence from medical devices and patients could be a game changer, improving patient-clinician communication, supporting earlier interventions and helping patients manage their condition.
Innovative approaches to real world evidence collection present opportunities for medical device companies to improve patient outcomes. But success will depend on improving the way medtech companies integrate digital health. Executives from Abbott, Smith & Nephew, AliveCor and Huma weigh in on these issues.
With its two major announcements at the Global Health Conference & Exhibition in Orlando, the company signaled it is aiming to help providers access more in-depth, real-time patient data to improve clinical decision-making and care.
AliveCor's at-home EKG device won FDA clearance to calculate a heart's QT interval, a measurement of how long it takes the ventricles to contract and relax. This is vital given that some drugs can lead to QT prolongation, which can increase the risk of certain arrhythmias.
The digital health company filed a complaint with the Federal Trade Commission last week, seeking a ban on the import of the Apple Watch. AliveCor cited copyright violations related to Apple’s ECG feature as the reason for seeking the ban.
The Covid-19 pandemic is altering behavior and fueling demand for remote technologies in clinical trials with Medable, a company in the clinical trial software space, looking to capitalize.
The startup, which has developed a portable ECG device, received clearance for algorithms to detect more cardiac conditions, such as premature contractions.
We are taking a look at how health insurers are using AI, defining success, and managing cybersecurity risks. Give us your opinions by completing our brief, anonymous survey.
MedCity News caught up with Omron Healthcare CEO Ranndy Kellogg at the the AdvaMed Digital MedTech Conference in San Francisco to speak about the company's new products, emerging business lines and how collaboration with other companies have driven recent innovation.
The Microsoft co-founder and billionaire philanthropist's choices for the healthcare innovations that have the potential to change the world range from personalized cancer vaccines to voice assistants.
The pre-order price of the device is $499 and it will be available in retail stores starting in January.
AliveCor's Kardiaband is designed to help consumers manage the task of detecting Afib, a form of heart arrhythmia and will help Apple bolster its relevance to healthcare.
Although Long QT syndrome can be inherited and acquired, the inherited version of the condition can leave up to 160,000 vulnerable to the disease.